The present disclosure provides a method for producing an electrolyte solution which can contain a high concentration of microbubbles, and a method for producing a microbubble-containing solvent which can be used for preparing the electrolyte solution, by suppressing decrease in microbubbles during filtration.

The present disclosure provides a method for producing an electrolyte solution which can contain a high concentration of microbubbles, and a method for producing a microbubble-containing solvent which can be used for preparing the electrolyte solution, by suppressing decrease in microbubbles during filtration.

The present invention relates to a combination therapy of cycloserine and lithium for the prevention or treatment of depression. The combined administration of cycloserine and lithium according to the present invention has a remarkably excellent effect of preventing or treating depression compared to each single administration, thereby being effectively utilized as a combination therapy for antidepressants.

The present invention relates to a combination therapy of cycloserine and lithium for the prevention or treatment of depression. The combined administration of cycloserine and lithium according to the present invention has a remarkably excellent effect of preventing or treating depression compared to each single administration, thereby being effectively utilized as a combination therapy for antidepressants.

A hydrogen addition device adds hydrogen to a biocompatible solution of a liquid containing body formed by the biocompatible solution sealed in a molecular hydrogen permeable container. The hydrogen addition device is provided with a tank for housing the unopened liquid containing body, a hydrogen water generator for producing dissolved hydrogen water formed by water with hydrogen dissolved therein to supply to the tank, and a heating portion for heating the dissolved hydrogen water in the tank to warm the biocompatible solution of the liquid containing body.

The present invention generally relates to supplement compositions for patients receiving current or chronic nitrous oxide treatment.

The present invention generally relates to supplement compositions for patients receiving current or chronic nitrous oxide treatment.

The present disclosure provides an improvement of existing L-arginine containing supplements by providing both hydrogen crystals (H.sub.2) and co-enzyme Q10 (Co-Q10) to produce a nutrient formulation, including compositions containing said formulation and methods of administering such formulation.

The present disclosure provides an improvement of existing L-arginine containing supplements by providing both hydrogen crystals (H.sub.2) and co-enzyme Q10 (Co-Q10) to produce a nutrient formulation, including compositions containing said formulation and methods of administering such formulation.

A system and a method are provided for making hypochlorous acid using saltwater with sodium bicarbonate. The system includes an electrolytic cell, a quantity of saltwater solution, and a quantity of sodium bicarbonate. The quantity of saltwater solution is poured into the electrolytic cell and then undergoes an electrolytic process. As a result of the quantity of saltwater solution going through the electrolytic process, a hypochlorous acid solution is yielded. In order to ensure a pure hypochlorous acid solution is formed, the quantity of sodium bicarbonate can be added into the electrolytic cell along with the quantity of saltwater solution before the electrolytic process or the quantity of sodium bicarbonate can be added into the hypochlorous acid solution after the hypochlorous acid solution is yielded. This process adjusts the pH level of the hypochlorous acid solution, and thus, produces a purer hypochlorous acid solution.